iThe current values are delayed, open demat account for live values.
BSE HC
BSE HC Performance
-
Open
42,625.35
-
High
42,988.46
-
Low
42,468.00
-
Prev Close
42,441.98
-
Dividend Yeild
0.51%
-
P/E
40.75
BSE HC Sector Performance
Top Performing
| Sector Name | Percentage Change |
|---|---|
| Diamond, Gems and Jewellery | 0.29 |
| IT - Hardware | 1.16 |
| Leather | 1.32 |
| Ceramic Products | 1.95 |
Under Performing
| Sector Name | Percentage Change |
|---|---|
| Real Estate Investment Trusts | -0.24 |
| Tobacco Products | -1.26 |
| Paints/Varnish | -0.41 |
| Oil Drill/Allied | -0.32 |
Stocks Performance
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Astrazeneca Pharma India Ltd | ₹19598 Cr |
₹7960.05
(0.31%)
|
1946 | Pharmaceuticals |
| Bliss GVS Pharma Ltd | ₹1266 Cr |
₹123.95
(0.42%)
|
35402 | Pharmaceuticals |
| Abbott India Ltd | ₹64942 Cr |
₹30720
(1.55%)
|
428 | Pharmaceuticals |
| Cipla Ltd | ₹121122 Cr |
₹1491
(1.07%)
|
53401 | Pharmaceuticals |
| Procter & Gamble Health Ltd | ₹8615 Cr |
₹5271
(5.01%)
|
437 | Pharmaceuticals |
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 17.3975 | 0.85 (5.12%) |
| Nifty 10 Yr Benchmark G-Sec | 2593.99 | 0.27 (0.01%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 920.77 | -0.39 (-0.04%) |
| Nifty 100 | 25552 | -41.1 (-0.16%) |
| Nifty 100 Alpha 30 Index | 17873.9 | 39.85 (0.22%) |
Latest News
- May 19, 2025
Markets across the Asia-Pacific region kicked off the week cautiously. The reason? A one-two punch: Moody’s just downgraded the U.S. credit rating, and China released some economic data that left investors scratching their heads. The ripple effects were felt far and wide, with the U.S. and China being key financial players.
- May 19, 2025
India's corporate bond market just got a significant upgrade. The Securities and Exchange Board of India (SEBI) is rolling out several key reforms designed to make things clearer, simpler, and more efficient for investors and issuers.
Latest Blogs
Investing for the next decade requires a careful selection of companies with strong fundamentals, consistent growth, and a clear long-term vision. India’s growing economy, rising consumer base, and digital transformation offer excellent opportunities for patient investors.
- May 19, 2025
Accretion Pharmaceuticals Limited, incorporated in 2012, is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products. The Accretion Pharmaceuticals IPO comes with a total issue size of ₹29.75 crore, comprising entirely a fresh issue of 29.46 lakh shares. The IPO opened on May 14, 2025, and closed on May 16, 2025.
- May 19, 2025
